Prelude Therapeutics PRLD
NASDAQ PRLD
$3.65 -0.14 (-3.69%)
As of: Oct 2, 2026 · 3:47 PM EDT

Prelude Therapeutics (PRLD) Price to Sales (2025 - 2026)

Updated

Prelude Therapeutics' (PRLD) Price to Sales was 18.97 for Q2 2026, up 115.7% from 8.79 a year earlier and up 16.4% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Price to Sales at Prelude Therapeutics was 15.05, up 9.4% from FY2024.

  • By year, Price to Sales came in at 13.75 in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 16.29 (Q1 2026), 15.05 (Q4 2025) and 8.62 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Prelude Therapeutics 312.03 Mn -285.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.97
Mar 31, 2026 16.29
Dec 31, 2025 15.05
Sep 30, 2025 8.62
Jun 30, 2025 8.79
API Access

Prelude Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=PRLD&period=max&api_key=YOUR_API_KEY